Stock Quality:
Last 7 days
4.6%
Last 30 days
26.9%
Last 90 days
-5.9%
Trailing 12 Months
-40.7%
AMRN RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Revenue Breakdown
| |||||||||||||||
| |||||||||||||||
|
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 277.5M | 264.8M | 241.0M | 228.6M |
2023 | 360.5M | 346.3M | 322.4M | 306.9M |
2022 | 535.6M | 475.6M | 423.4M | 369.2M |
2021 | 601.2M | 620.4M | 605.9M | 583.2M |
2020 | 511.5M | 546.0M | 590.1M | 614.1M |
2019 | 258.6M | 306.7M | 363.8M | 429.8M |
2018 | 190.4M | 197.8M | 205.8M | 229.2M |
2017 | 139.2M | 151.3M | 165.9M | 181.1M |
2016 | 91.4M | 106.8M | 118.0M | 130.1M |
2015 | 59.2M | 64.3M | 71.6M | 81.8M |
2014 | 35.0M | 42.1M | 47.8M | 54.2M |
2013 | 0 | 0 | 0 | 26.4M |
CEO | Mr. Patrick Holt |
---|---|
WEBSITE | amarincorp.com |
SECTOR | Healthcare |
INDUSTRY | Drug Manufacturers General |
EMPLOYEES | 365 |